# Hyperbaric Oxygen Therapy for Prodromal Alzheimer´s Disease With Cerebrovascular Disease

> **NCT05349318** · NA · UNKNOWN · sponsor: **Assaf-Harofeh Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Prodromal Alzheimer's Disease
- Cerebral Vascular Disorder
- Mild Cognitive Impairment
- Vascular Cognitive Impairment

## Interventions

- **DEVICE:** Hyperbaric oxygen therapy
- **DEVICE:** Sham

## Key facts

- **NCT ID:** NCT05349318
- **Lead sponsor:** Assaf-Harofeh Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-31
- **Primary completion:** 2024-08
- **Final completion:** 2025-03
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05349318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05349318, "Hyperbaric Oxygen Therapy for Prodromal Alzheimer´s Disease With Cerebrovascular Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05349318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*